Synthetic biology
Engineered cells are opening new routes for medicines, materials and sustainable production in UK research clusters.
Read the research
Biotechnology, health and life sciences
Advancing health through innovation
Engineering biology, digital health and precision medicine are changing how care is discovered, delivered and measured. Peak Forge Ltd. follows the evidence behind that change.
Clear reporting for clinicians, investors and biotech founders.
The field at a glance
Areas of focus
The strongest life sciences stories connect a research result with a real decision. These are the fields we track closely.
Biotech
Follow platform technologies, capital raises, licensing deals and the practical work of moving discoveries into development.
Track company activityDigital health
See where remote monitoring, connected care and clinical software are gaining trust with patients and NHS teams.
Explore digital careMedtech innovation
Devices succeed when clinical value, usability and regulation meet. We examine all three before adoption.
Follow device progressPrecision medicine
Biomarkers and better patient stratification are changing treatment choices, trial design and clinical evidence.
Read clinical analysisGenomics
Milestones in sequencing and population data matter when they improve diagnosis, prevention or treatment decisions.
Follow genomics newsCompany watch
UK biotech startups to watch
Funding is only the first signal. We look at the science, the development stage and the route to a useful product.
O
Oxford cluster
Orchard Cell Systems
Cell-engineering tools for more consistent therapeutic development. Series A stage with a focus on laboratory partnerships.
- Reported funding
- £18m
- Focus
- Cell therapy
"The assay has to work outside our own lab."
C
Cambridge cluster
Calyx Genomics
A genomic interpretation platform built for rare disease teams. The company is preparing evidence for clinical deployment.
- Reported funding
- £11m
- Focus
- Genomics
"Interpretation is where patients need clarity."
N
Scotland
Northstar Remote Care
Connected monitoring for respiratory pathways. Its pilot work is centred on earlier review and fewer avoidable appointments.
- Reported funding
- £7.5m
- Focus
- Remote care
"A useful alert reaches the right team."
Evidence in practice
Promising clinical developments
Clinical progress earns attention when the result changes a decision for patients or providers.
18 March 2025 · Phase II
A biomarker-led treatment study reports stronger response in a defined patient group
The result supports a precision medicine approach and gives trial teams a clearer basis for selecting participants.
Read the analysis06 February 2025 · MHRA decision
A connected cardiac monitor moves into a wider clinical service
The adoption case rests on dependable readings, clear escalation rules and a workflow that fits existing teams.
See what changed22 January 2025 · Genomics milestone
A rare disease programme shortens the path to a confirmed diagnosis
Better sequencing and interpretation can reduce uncertainty for families and guide specialist referrals earlier.
Follow the evidenceCare beyond the clinic
Digital health in the NHS and beyond
Remote patient monitoring can give care teams a better view between appointments. Adoption depends on privacy, interoperability and a clear answer to who acts on the signal.
The best services reduce avoidable delay without placing another disconnected dashboard in front of staff.
Read the connectivity brief24/7
Potential visibility
Patient-generated data can support earlier review between visits.
3 tests
For practical adoption
Privacy, interoperability and staff workflow must align.
NHS
Real service context
A pilot matters when it fits the pressure of daily care.
Practical routes
From research to market
A strong result needs a plan for validation, regulation and payment. UK teams must make each gate visible early.
1
Lab validation
Define the result and reproduce it beyond the original team.
2
Regulatory review
Map the MHRA pathway and build the required technical file.
3
Clinical trials
Test safety, performance and patient value with a clear protocol.
4
Reimbursement
Prepare the evidence NHS commissioners and NICE need to assess value.
5
Scale-up
Make manufacturing, training and support work at service level.
A useful founder prompt
Which evidence will change the next buyer's decision?
News desk
Latest biotech and health news
Short, evidence-led updates on research, startups, approvals and clinical adoption.
Genomics · 7 min read
What a new sequencing milestone means for rare disease teams
The clinical value sits in interpretation, referral timing and how results reach families.
Read storyDigital health · 5 min read
Remote monitoring needs an escalation plan before it needs more data
A practical look at alerts, handovers and the measures that make connected care useful.
Read storySynthetic biology · 8 min read
The questions investors should ask before backing a platform
Reproducibility, manufacturing plans and a credible customer need separate promise from progress.
Read storyKeep up with life sciences technology
Receive a concise briefing on research, funding and clinical impact.